SW 780 In Vitro RNA Expression Analysis Assay (Cap Analysis) (CAT#: ITS-1022-YF3135)

SW 780

Human

The SW 780 line was established in 1974 by A. Leibovitz from a grade I transitional cell carcinoma.

SW-780, SW780

Bladder Cancer

Oncology

In Vitro RNA Expression Analysis Assay (Cap Analysis)

SW 780-cell based In Vitro RNA Expression Analysis Assay (Cap Analysis)

Cap analysis gene expression involves the sequencing of PCR-amplified cDNA tags obtained from the 5' end of mRNA. For the identification of starting sites of transcription, the cap analysis gene expression technique has become a useful platform.

Gene and Protein Expression Assays

Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.